Latest News & Features
Americas
Teva announced yesterday that the Federal Trade Commission has accepted its proposed $40.5 billion buyout of Allergan’s generics business after the Isreal-based company agreed to sell nearly 80 products to address competition concerns. 28 July 2016
Americas
Bayer and Janssen Pharmaceuticals have sued Breckenridge Pharmaceutical for allegedly infringing two patents related to the deep vein thrombosis treatment drug Xeralto. 28 July 2016
Europe
The European Patent Office has announced several reforms to its patent opposition procedures. Stephanie Pilkington and Ling Zhuang of Potter Clarkson consider some of their implications for centralised patent revocation in Europe from a life sciences perspective. 28 July 2016
Big Pharma
GSK announced today that it will invest £275 million in expanding its UK manufacturing capabilities, despite Brexit. 27 July 2016
Americas
The US Court of Appeals for the Federal Circuit yesterday affirmed a district court’s order to deny arbitration in a patent infringement case between Illumina and Ariosa Diagnostics. 27 July 2016
Big Pharma
The Irish Pharmaceutical Healthcare Association has agreed a deal with the government that it says will reduce costs paid by the country’s Health Service Executive to facilitate access to new medicines. 26 July 2016
Americas
Law firm Cooley announced yesterday that it is expanding its patent counselling and prosecution practice with the addition of Mika Reiner Mayer’s team from law firm Morrison Foerster. 26 July 2016
Biotechnology
In order to be well prepared before a generic or biosimilar marketing authorisation is approved, drugs companies in the EU may consider monitoring pending applications, says Ruth Franken of Hogan Lovells. 26 July 2016
Americas
Technology company Philips has bought Wellcentive, a US-based company that provides health management solutions. 25 July 2016
Americas
The US Drug Enforcement Administration has claimed that hundreds of thousands of counterfeit pills containing deadly substances have entered the US drug market. 25 July 2016